The complete blood count (CBC) is the most common test ordered on our patients. Most hematology/oncology nurses only glance briefly, however, at a patient’s CBC to determine if they meet criteria for chemotherapy administration, blood transfusion, or emergent antibiotics. Have you ever looked beyond the Hgb, PLT, and ANC and wondered what the MCV or IPF may indicate?
When is a high or low reticulocyte count significant? And when do you need to worry about leukocytosis or thrombocytosis? The components of the CBC can provide valuable information to formulate a differential diagnosis, direct management, or guide the focus of further evaluation. Join this interactive session investigating CBCs in a variety of clinical scenarios. First, we’ll review pertinent lab results, history, and exam findings. Are the CBC values expected or cause for concern? Do we need any additional tests? Armed with this knowledge, we’ll determine if any adjustments in therapy are indicated and what future monitoring and family education are required.
- Closing Keynote: Why We Chose Nursing and How Nursing Continues to Choose Us (104)
- General Session: Emotional Intelligence: A Daily Practice (103)
- General Session: Controversies and Conundrums in the Use of Opioids in AYAs with Cancer (102)
- Opening Keynote: The American Nurse: Stories of Life-Changing Impact (101)
- Paper Presentation: Education Across the Cancer Care Continuum — Evidence-Based Interprofessional Palliative Care Education: Lessons for Pediatric Oncology Clinicians (204-2)
- Karyn Brundige, MSN CPNP
- CNE Hours: